Original Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Hepatol. Jan 27, 2013; 5(1): 26-32
Published online Jan 27, 2013. doi: 10.4254/wjh.v5.i1.26
Table 4 Associations of patient and donor characteristics with graft survival (graft loss or death endpoint) and patient survival (death endpoint) in intensive care unit patients
Association with graft survival (graft loss or death endpoint)Association with patient survival (death endpoint)
VariableRelative risk (95%CI)P valueRelative risk (95%CI)P value
Patient characteristics
Age at transplant (10 yr increase)0.98 (0.49-1.99)0.961.00 (0.47-2.11)0.99
Gender (male)1.33 (0.42-4.19)0.631.10 (0.34-3.61)0.88
BMI (10 unit increase)0.63 (0.24-1.66)0.350.57 (0.20-1.59)0.28
Diagnosis
Hepatitis C0.99 (0.32-3.08)0.990.79 (0.24-2.59)0.69
ETOH0.57 (0.12-2.59)0.460.65 (0.14-3.02)0.58
Cryptogenic cirrhosis3.29 (0.97-11.15)0.0563.97 (1.14-13.87)0.031
MELD at transplant (5 unit increase)0.99 (0.63-1.57)0.971.09 (0.68-1.75)0.72
MELD at ICU admission (5 unit increase)0.85 (0.56-1.30)0.471.03 (0.66-1.61)0.89
Previous operation1.07 (0.31-3.67)0.910.76 (0.20-2.95)0.69
Vasopressors1.06 (0.32-3.51)0.931.24 (0.36-4.23)0.74
Vasopressin0.78 (0.23-2.59)0.680.91 (0.27-3.11)0.88
Norepinephrine0.29 (0.04-2.22)0.230.32 (0.04-2.51)0.28
Vasopressin and norepinephrine0.44 (0.06-3.44)0.440.50 (0.06-3.90)0.51
Length of time from hospital admission to ICU admission (doubling)0.91 (0.64-1.28)0.570.88 (0.61-1.27)0.49
Ambulation1.30 (0.36-4.72)0.691.30 (0.36-4.72)0.69
Dialysis1.70 (0.46-6.32)0.431.46 (0.38-5.54)0.58
Tracheostomy1.00 (0.27-3.71)1.000.61 (0.13-2.83)0.53
Mechanical ventilation0.91 (0.29-2.88)0.880.69 (0.20-2.37)0.56
Donor characteristics
Age (10 yr increase)0.97 (0.67-1.41)0.880.91 (0.61-1.36)0.65
Gender (male)0.74 (0.21-2.63)0.640.52 (0.13-2.09)0.36
Recipient-donor gender incompatibility1.33 (0.36-4.91)0.671.76 (0.45-6.87)0.41
Donation after cardiac death3.38 (0.95-12.05)0.0604.19 (1.12-15.70)0.033
Donor risk index (1 unit increase)2.15 (0.54-8.62)0.281.61 (0.36-7.15)0.53